Clinical Trial Update: A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind, crossover trial comparing onset of action of Parcopa with Sinemet in adults with stable Parkinson's disease; the study is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Parcopa (carbidopa-levodopa)
• SINEMET (carbidopa and levodopa)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED